Healthcare

Johnson & Johnson

Symbol: JNJ
271.11 €
+3.33%
KGV
30.4
Dividende
2.04%
Marktkap.
653.3 Mrd
52W Hoch
274.90 €
52W Tief
173.33 €

Live Chart

Über Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as op

Aktuelle Finanznachrichten

Hinweis: Diese Daten dienen nur zur Information und stellen keine Anlageberatung dar. Aktualisiert: 19.08.2026 11:00
| YouTube